Literature DB >> 9257734

Variability of chromosomally encoded beta-lactamases from Klebsiella oxytoca.

B Fournier1, P H Roy.   

Abstract

The beta-lactamase genes of Klebsiella oxytoca were previously divided into two main groups: bla(OXY-1) and bla(OXY-2). The two beta-lactamase groups were each represented by beta-lactamases with four different pIs. In each group, one form of beta-lactamase is more frequent than the others combined. The beta-lactamase gene of each representative beta-lactamase with a different pI that was not yet sequenced (pIs 5.7, 6.8 [OXY-2], 7.1, 8.2, and 8.8 [OXY-1]) was cloned and sequenced. The susceptibility patterns as well as relative rates and kinetic parameters for beta-lactam hydrolysis revealed that OXY-2 enzymes hydrolyzed several of the beta-lactams that were examined (carbenicillin, cephalothin, cefamandole, ceftriaxone, and aztreonam) at a greater rate than the OXY-1 enzymes did. Comparison of K. oxytoca beta-lactamases with plasmid-mediated extended-spectrum beta-lactamases MEN-1 and TOHO-1 implied that the threonine at position 168 present in OXY-2 beta-lactamase instead of the alanine in OXY-1 could be responsible for its modified substrate hydrolysis. In each group, the beta-lactamase with a variant pI differs from the main form of beta-lactamase by one to five amino acid substitutions. The substrate profile and the 50% inhibitory concentrations revealed that all substitutions differing from the main form of beta-lactamase were neutral except one difference in the OXY-1 group. This substitution of an Ala to a Gly at position 237 increases the hydrolysis of some beta-lactams, particularly aztreonam; decreases the hydrolysis of benzylpenicillin, cephaloridine, and cefamandole, and decreases the susceptibility to clavulanic acid (fivefold increase in the 50% inhibitory concentration).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257734      PMCID: PMC163978     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates.

Authors:  K Kimura; Y Arakawa; S Ohsuka; H Ito; K Suzuki; H Kurokawa; N Kato; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

2.  Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca.

Authors:  B Fournier; C Y Lu; P H Lagrange; R Krishnamoorthy; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 3.  Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.

Authors:  J R Knox
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 4.  Genetics of extended-spectrum beta-lactamases.

Authors:  G A Jacoby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

5.  Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.

Authors:  T Palzkill; Q Q Le; K V Venkatachalam; M LaRocco; H Ocera
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

6.  Sequence diversity among related genes for recognition of specific targets in DNA molecules.

Authors:  J A Gough; N E Murray
Journal:  J Mol Biol       Date:  1983-05-05       Impact factor: 5.469

7.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

8.  Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.

Authors:  B Fournier; P H Roy; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors.

Authors:  B Fournier; P H Lagrange; A Philippon
Journal:  J Antimicrob Chemother       Date:  1996-05       Impact factor: 5.790

10.  Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.

Authors:  Y Ishii; A Ohno; H Taguchi; S Imajo; M Ishiguro; H Matsuzawa
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

View more
  15 in total

1.  The extended-spectrum K1 beta-lactamase from Klebsiella oxytoca SC 10,436 is a member of the bla(OXY-2) family of chromosomal Klebsiella enzymes.

Authors:  Sophie A Granier; Véronique Leflon-Guibout; Marie-Hélène Nicolas-Chanoine; Karen Bush; Fred W Goldstein
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.

Authors:  P Giakkoupi; L S Tzouvelekis; A Tsakris; V Loukova; D Sofianou; E Tzelepi
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area.

Authors:  S W Wu; K Dornbusch; G Kronvall
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  Outbreak of OXY-2-Producing Klebsiella oxytoca in a renal transplant unit.

Authors:  Mariela Soledad Zárate; Ana C Gales; Renata C Picão; Gervasio Soler Pujol; Alejandra Lanza; Jorgelina Smayevsky
Journal:  J Clin Microbiol       Date:  2008-04-16       Impact factor: 5.948

5.  Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam.

Authors:  L Ma; Y Ishii; M Ishiguro; H Matsuzawa; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

6.  Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Magdalena A Taracila; Elise T Zeiser; Julian A Gatta; John J LiPuma; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

7.  Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.

Authors:  D Sirot; R Labia; P Pouedras; C Chanal-Claris; C Cerceau; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

8.  Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca.

Authors:  B Fournier; A Gravel; D C Hooper; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

9.  New Klebsiella oxytoca beta-lactamase genes bla(OXY-3) and bla(OXY-4) and a third genetic group of K oxytoca based on bla(OXY-3).

Authors:  Sophie A Granier; Véronique Leflon-Guibout; Fred W Goldstein; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  In vivo selection of a chromosomally encoded beta-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca.

Authors:  Hedi Mammeri; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.